NASDAQ: NCEL
NewcelX Ltd.
$3.77
▲ +0.11 (+2.93%)as of 2026-07-01
1-year price · 252 sessions
Key stats
52-week range$3.77
$1.88$28.60
Today
- Open
- 3.95
- Day high
- 3.95
- Day low
- 3.40
- Prev close
- 3.66
- Volume
- 118K
Valuation
- Mkt cap
- $20M
- P/E (TTM)
- —
- EPS (TTM)
- —
- P/B
- 7.0
- P/S
- —
Dividend
- Yield
- —
- Per share
- —
Insider & institutional activity · SEC Form 4 / 13F
- ▲Insiders net buying $952K over the last 3 months (4 open-market buys, 0 sales)
- ◆Cluster buying — multiple insiders bought within days
- 🏛Institutions accumulating (13F)
NewcelX Ltd. (NCEL) is a Healthcare company listed on NASDAQ. The stock is down 87% over the past year. Over the trailing 3 months, insiders filed 4 open-market buys and 0 sales (SEC Form 4).
NewcelX Ltd. (NCEL) financials & analyst ratings
Fundamentals (TTM)
Margins
Gross margin—
Operating margin—
Net margin—
FCF margin—
Growth & returns
Revenue growth—
Revenue growth (fwd)—
EPS growth—
Return on equity-145.9%
Return on assets-97.0%
Source: exchange market data + company filings. Figures are trailing-twelve-month or as most recently reported. For informational purposes only — not investment advice.
NCEL earnings date, history & EPS estimates
Next earnings
Sep 2, 2026in NaN days
Track record
Beat EPS in 4 of 4 quarters
Avg surprise +97.2% (last 4 quarters)
Earnings history
| Report date | EPS est | EPS actual | Surprise | Revenue | Rev. surprise |
|---|---|---|---|---|---|
| May 15, 2024 | $-8.40 | $-0.00 | +100.0% | — | — |
| May 5, 2023 | $-12.00 | $-0.29 | +97.5% | — | — |
| Oct 11, 2022 | — | $-0.54 | — | — | — |
| Mar 24, 2022 | $-13.80 | $-0.50 | +96.4% | — | — |
| May 14, 2021 | $-6.80 | $-0.34 | +95.0% | — | — |
| Jun 29, 2019 | — | $-0.31 | — | — | — |
NCEL insider trading activity (SEC Form 4)
Sentiment
100/100
Buys (3m)
4
Sells (3m)
0
Net (3m)
$952.5K
Insiders buyingCluster buying
Context3-month price +43.7%Institutions accumulating (13F)
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Apr 29, 2026 | Samuel Olivierdirector | Buy | 81,818 | $2.75 |
| Apr 29, 2026 | Samuel Olivierdirector | Buy | 114,545 | $3.02 |
| Apr 29, 2026 | Revel Micheldirector, 10 percent owner, officer: CSO and Director | Buy | 54,545 | $2.75 |
| Apr 29, 2026 | Revel Micheldirector, 10 percent owner, officer: CSO and Director | Buy | 76,363 | $3.02 |
Source: NCEL SEC Form 4 filings, latest Apr 29, 2026. For informational purposes only — not investment advice.
See the full NCEL insider & 13F page →Track NCEL with Drillr
SEC filings, earnings calls, insider activity, alt-data signals — all queryable through Drillr's AI terminal and MCP API.
Try Drillr for free